Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide.
Although a cadre of therapeutic strategies have been made available for CVDs in the clinical …

Cardiovascular diseases (CVDs) are a leading cause of death and disability worldwide.
Given the current challenges in recognizing and managing CVDs, the initial and long-term …

Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality
worldwide. However, despite the recent developments in the management of CVDs, the …

Cardiovascular diseases (CVDs) are one of the foremost causes of high morbidity and
mortality globally. Preventive, diagnostic, and treatment measures available for CVDs are …

Nanoparticles are exclusively suitable for studying and developing potential therapies
against cardiovascular diseases (CVD) because of their size, fine-tunable properties, and …

Cardiovascular disease (CVD) encompasses all pathologies of the heart or circulatory
system, including coronary heart disease, peripheral vascular disease and stroke …

Cardiovascular diseases (CVDs) represent the most important epidemic of our century, with
more than 37 million patients globally. Furthermore, CVDs are associated with high …

It has been reported that death related to cardiovascular disease has increased up to 12.5%
just in the past decade alone with various factors playing a role. In 2015 alone, it has been …

A large majority of cardiovascular nanomedicine research has focused on fabricating
designer nanoparticles for improved targeting as a means to overcome biological barriers …

Cardiovascular diseases (CVD) is a general term for disorders affecting the heart or blood
vessels and represent a major cause of disability and death worldwide [1]. There are …